SERVICES
technology
Our strong expertise in IP and technology assessment and experience with the FDA regulations and the U.S. generic pharmaceutical market also enables us to provide turn-key solutions to our international investors who want to enter into the U.S. generic market, from project evaluation to product development, bioequivalence evaluation, ANDA submission, commercial manufacturing and sales & marketing following ANDA approval.


PRODUCTS



